V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20201533 | 20167090 | 1.76 | 66.8 | Palliative (P) | 2019-06-07 | 2019-09-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101423836 |
| 20201534 | 20167091 | 1.82 | 61 | null | 2019-10-27 | 2019-11-24 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100804727 |
| 20201568 | 20167092 | 1.76 | 66.8 | Palliative (P) | 2022-02-21 | 2022-02-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100602496 |
| 20201574 | 20167093 | 1.83 | 102 | null | 2021-04-04 | 2021-04-25 | Docetaxel | 02 | null | DOCETAXEL | 100254819 |
| 20201577 | 20167094 | 1.83 | 54 | Palliative (P) | 2016-08-08 | 2016-08-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100690335 |
| 20201580 | 20167095 | 1.7 | 50.6 | Palliative (P) | 2018-06-03 | 2018-07-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101387467 |
| 20201593 | 20167096 | 1.7 | 71.8 | Palliative (P) | 2022-03-02 | 2022-03-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101261241 |
| 20201595 | 20167097 | 1.72 | 50.8 | Palliative (P) | 2020-05-18 | 2020-06-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100669388 |
| 20201619 | 20167098 | 1.63 | 49.9 | Palliative (P) | 2018-09-30 | 2018-09-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100675235 |
| 20201628 | 20167099 | 1.68 | 52.3 | null | 2022-04-17 | 2022-04-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101669251 |
| 20201642 | 20167100 | 1.68 | 70.3 | Palliative (P) | 2018-03-06 | 2018-03-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100758934 |
| 20201649 | 20167101 | 1.61 | 69.2 | Palliative (P) | 2017-01-24 | 2021-05-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101453086 |
| 20201715 | 20167102 | 1.79 | 35.8 | null | null | 2020-08-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100077823 |
| 20201724 | 20167103 | 1.9 | 77.8 | null | null | 2020-04-06 | CETUXIMAB + IRINOTECAN + MDG | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100027957 |
| 20201726 | 20167104 | 1.61 | 59.9 | Palliative (P) | 2016-06-16 | 2016-07-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101617947 |
| 20201739 | 20167105 | 1.98 | 71.7 | Adjuvant (A) | 2021-08-01 | 2022-01-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100753610 |
| 20201742 | 20167106 | 1.76 | 82.2 | Palliative (P) | 2019-05-30 | 2019-06-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100593906 |
| 20201748 | 20167107 | null | 87.4 | null | 2018-10-02 | 2018-10-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101228385 |
| 20201750 | 20167108 | 1.72 | 68.4 | Palliative (P) | 2018-03-30 | 2018-05-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100542515 |
| 20201754 | 20167109 | null | 77.65 | Palliative (P) | 2018-02-12 | 2018-03-01 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100529441 |
| 20201759 | 20167110 | 1.76 | 88.2 | null | 2019-01-09 | 2021-02-08 | Cetuximab + FOLFIRI cycle 2 onwards | null | null | DOCETAXEL | 101330280 |
| 20201763 | 20167111 | 1.7 | 53 | null | null | 2018-09-07 | Docetaxel | 2 | null | DOCETAXEL | 101040728 |
| 20201774 | 20167112 | 1.85 | 72 | null | 2021-10-20 | 2021-10-23 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100099230 |
| 20201776 | 20167113 | 1.88 | 90.3 | Palliative (P) | null | 2021-03-16 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101364475 |
| 20201787 | 20167114 | 1.51 | 78.7 | Palliative (P) | 2019-06-29 | 2019-06-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101340302 |
| 20201799 | 20167115 | 1.62 | 88 | null | 2022-04-27 | 2022-05-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101490464 |
| 20201815 | 20167116 | 1.86 | 84.5 | null | 2019-08-21 | 2019-09-04 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101339598 |
| 20201822 | 20167117 | 1.53 | 46 | Palliative (P) | 2017-12-16 | 2018-01-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100667980 |
| 20201832 | 20167118 | 1.7 | 50 | Palliative (P) | 2021-04-03 | 2021-05-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100184278 |
| 20201853 | 20167119 | 1.72 | 65 | Curative (C) | 2021-12-18 | 2021-12-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100625540 |
| 20201868 | 20167120 | 1.7 | 49.5 | Palliative (P) | 2021-04-17 | 2021-05-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101035743 |
| 20201913 | 20167122 | 1.77 | 83.7 | Palliative (P) | 2020-09-17 | 2020-10-03 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101718790 |
| 20201914 | 20167123 | 1.61 | 43.3 | Palliative (P) | 2017-03-04 | 2017-03-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100799426 |
| 20201918 | 20167124 | 1.52 | 81.2 | Palliative (P) | 2020-04-28 | 2020-05-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100931650 |
| 20201922 | 20167125 | 1.74 | 96.6 | null | 2019-05-06 | 2019-07-20 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 100484326 |
| 20201925 | 20167126 | 1.66 | 65.5 | Palliative (P) | 2019-10-06 | 2019-10-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100896588 |
| 20201929 | 20167127 | null | 63 | Palliative (P) | 2019-02-27 | 2019-04-16 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101648048 |
| 20201943 | 20167128 | 1.75 | 60.6 | null | 2017-06-08 | 2017-12-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101112896 |
| 20201950 | 20167129 | 1.75 | 69.2 | null | 2021-11-23 | 2021-12-07 | Docetaxel | 02 | null | DOCETAXEL | 101710903 |
| 20201974 | 20167130 | 1.88 | 50.6 | null | 2022-03-13 | 2022-04-03 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101166664 |
| 20201999 | 20167131 | null | 94.4 | Palliative (P) | 2020-01-17 | 2020-02-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100501481 |
| 20202017 | 20167132 | 1.63 | 83 | Palliative (P) | 2021-06-16 | 2021-06-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100197157 |
| 20202037 | 20167133 | 1.63 | 51 | Palliative (P) | 2018-09-09 | 2018-09-23 | Docetaxel | 02 | N | DOCETAXEL | 101789395 |
| 20202057 | 20167134 | 1.67 | 60.8 | Palliative (P) | 2021-12-29 | 2022-01-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101106246 |
| 20202061 | 20167135 | 1.52 | 72 | Palliative (P) | 2019-05-26 | 2019-06-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100617260 |
| 20202095 | 20167136 | 1.59 | 78 | Palliative (P) | 2018-07-30 | 2018-08-02 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101284803 |
| 20202103 | 20167137 | 1.63 | 83.3 | null | 2018-06-08 | 2018-06-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101757255 |
| 20202129 | 20167138 | 1.89 | 61 | Palliative (P) | 2017-10-21 | 2017-11-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100299105 |
| 20202153 | 20167139 | 1.55 | 64.55 | null | 2018-11-19 | 2018-12-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101084616 |
| 20202206 | 20167140 | null | 88.6 | null | null | 2018-04-21 | Docetaxel 75mg/m2 (21 day) | N | null | DOCETAXEL | 100053695 |